Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Progressive Keratoconus, Corneal Ectasia

In brief

Prospective, randomized, single site study to determine the safety and effectiveness of performing corneal collagen cross-linking (CCCL)using riboflavin and UVA light in eyes with corneal ectasia or progressive keratoconus.

Key facts

Study ID

NCT00567671

Run by

Emory University

People needed

160

Starts

2007-12-01

Expected to finish

2010-06-01

Last updated by the study team

2010-09-02

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of keratoconus with documented progression over the previous 12 months.
• Diagnosis of corneal ectasia
• Must be able to complete all study visits

You may not qualify if…

• Prior corneal surgery in the keratoconus group
• Corneal scarring

Where it is running

• Woolfson Eye Institute — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.